Patents by Inventor Mariah R. Baughn

Mariah R. Baughn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7378492
    Abstract: Various embodiments of the invention provide human receptors and membrane-associated proteins (REMAP) and Q polynucleotides which identify and encode REMAP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of REMAP.
    Type: Grant
    Filed: February 18, 2003
    Date of Patent: May 27, 2008
    Assignee: Incyte Corporation
    Inventors: Narinder K. Chawla, Henry Yue, Thomas W. Richardson, Joseph P. Marquis, Patricia M. Lehr-Mason, Ann E. Gorvad, Shanya D. Becha, Amy E. Kable, Anita Swarnakar, Pei Jin, Phillip R. Hawkins, David Chien, Jayalaxmi Ramkumar, Uyen K. Tran, April J. A. Hafalia, Mariah R. Baughn, Soo Yeun Lee, Xin Jiang, Alan A. Jackson, Reena Khare, Sean A. Bulloch
  • Patent number: 7371832
    Abstract: The invention provides human molecules associated with cell proliferation (MACP) and polynucleotides which identify and encode MACP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of MACP.
    Type: Grant
    Filed: July 21, 1999
    Date of Patent: May 13, 2008
    Assignee: Incyte Corporation
    Inventors: Y. Tom Tang, Preeti Lal, Jennifer L. Hillman, Neil C. Corley, Chandra Arvizu, Mariah R. Baughn
  • Patent number: 7122362
    Abstract: The invention provides human phosphodiesterases (HPDE) and polynucleotides which identify and encode HPDE. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of HPDE.
    Type: Grant
    Filed: January 26, 2001
    Date of Patent: October 17, 2006
    Inventors: Mariah R. Baughn, Dyung Aina M. Lu, Henry Yue, Y. Tom Tang, Danniel B. Nguyen
  • Patent number: 7112426
    Abstract: The invention provides human human kinases (PKIN) and polynucleotides which identify and encode PKIN. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of PKIN.
    Type: Grant
    Filed: November 1, 2002
    Date of Patent: September 26, 2006
    Assignee: Incyte Corporation
    Inventors: Olga Bandman, Danniel B Nguyen, Narinder K Chawla, April J A Hafalia, Monique G Yao, Ameena R Gandhi, Rajagopal Gururajan, Li Ding, Chandra S Arvizu, Henry Yue, Mariah R Baughn, Catherine M Tribouley, Michael B Thornton, Vicki S Elliott, Yan Lu, Craig H Ison, Janice K Au-Young, Y Tom Tang, Yalda Azimzai, John D Burrill, Gregory A Marcus, Kurt A Zingler, Dyung Aina M Lu, Preeti G Lai, Jayalaxmi Ramkumar, Bridget A Warren, Liam Kearney, Jennifer L Policky, Kavitha Thangavelu, Neil Burford
  • Patent number: 7105315
    Abstract: The invention provides a transmembrane protein that is differentially expressed in neoplastic disorders. It also provides for the use of the protein, a cDNA encoding the protein, and antibodies that specifically bind the protein in various methods to diagnose, stage, treat, or monitor the treatment of a neoplastic disorder.
    Type: Grant
    Filed: July 1, 2002
    Date of Patent: September 12, 2006
    Assignee: Incyte Genomics, Inc.
    Inventors: Amy K. W. Lasek, Mariah R. Baughn, Yalda Azimzai
  • Patent number: 7029897
    Abstract: The invention provides human kinases and phosphatases (KAP) and polnucleotides which identify and encode KAP. The invention also provides expresson vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of KAP.
    Type: Grant
    Filed: December 4, 2001
    Date of Patent: April 18, 2006
    Assignee: Incyte Corporation
    Inventors: Henry Yue, Li Ding, Preeti G. Lal, Jennifer A. Griffin, Rajagopal Gururajan, Mariah R. Baughn, Craig H. Ison, Jayalaxmi Ramkumar, Catherine M. Tribouley, Anita Swarnakar, Neil Burford, Olga Bandman, Michael Thornton, Farrah A. Khan, Narinder K. Chawla, Danniel B. Nguyen, Vicki S. Elliott, Yuming Xu, Yan Lu, April J. A. Hafalia, Monique G. Yao, Ameena R. Gandhi, Chandra S. Arvizu, Ian J. Forsythe
  • Patent number: 6927056
    Abstract: The invention provides a human cysteine proteases and polynucleotides which encode those proteases. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists, as well as methods for diagnosing, treating, or preventing disorders associated with aberrant expression of cysteine proteases.
    Type: Grant
    Filed: September 6, 2001
    Date of Patent: August 9, 2005
    Assignee: Incyte Corporation
    Inventors: Stephen Todd, Angelo M. Delegeane, Ameena R. Gandhi, Danniel B. Nguyen, April J. A. Hafalia, Liam Kearney, Yan Lu, Ernestine A. Lee, Narinder K. Chawla, Debopriya Das, Chandra S. Arvizu, Monique G. Yao, Deborah A. Kallick, Vicki S. Elliott, Li Ding, Henry Yue, Roopa M. Reddy, Dyung Aina M. Lu, Jayalaxmi Ramkumar, Junming Yang, Catherine M. Tribouley, Neil Burford, Mariah R. Baughn, Preeti G. Lal, Mark L. Borowsky, Farrah A. Khan, Rajagopal Gururajan, Y. Tom Tang, Janice K. Au-Young, Bridget A. Warren, Roberto Hernandez, Brendan M. Duggan
  • Patent number: 6872560
    Abstract: The invention provides human hydrolytic enzymes (HYENZ) and polynucleotides which identify and encode HYENZ. The invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of HYENZ.
    Type: Grant
    Filed: August 31, 2000
    Date of Patent: March 29, 2005
    Assignee: Incyte Corporation
    Inventors: Henry Yue, Jennifer L. Hillman, Y. Tom Tang, Mariah R. Baughn, Dyung Aina M. Lu, Yalda Azimazai
  • Patent number: 6838241
    Abstract: The invention provides human protein transport molecules (PTAM) and polynucleotides which identify and encode PTAM. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of PTAM.
    Type: Grant
    Filed: August 26, 1999
    Date of Patent: January 4, 2005
    Assignee: Incyte Corporation
    Inventors: Y. Tom Tang, Preeti Lal, Olga Bandman, Henry Yue, Neil C. Corley, Karl J. Guegler, Gina A. Gorgone, Mariah R. Baughn, Chandra Patterson
  • Publication number: 20040265807
    Abstract: The invention provides human enzymes (NZMS) and polynucleotides which identify and encode NZMS. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of NZMS.
    Type: Application
    Filed: March 8, 2004
    Publication date: December 30, 2004
    Inventors: Madhusudan M Sanjanwala, Yan Lu, Ernestine A Lee, April J A Hafalia, Bridget A Warren, Mariah R Baughn, Y Tom Tang, Henry Yue, Monique G Yao, Sally Lee, Michael B Thornton, Narinder K Chawla, Yuming Xu, Uyen K Tran, Preeti G Lal, Dyung Aina M Lu, Anita Swarnakar, Huijun Z Ring, Karen A Jones
  • Publication number: 20040258679
    Abstract: The invention provides human vesicle-associated proteins (VAP) and polynucleotides which identify and encode VAP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of VAP.
    Type: Application
    Filed: March 29, 2004
    Publication date: December 23, 2004
    Inventors: Bridget A Warren, Kavitha Thangavelu, Henry Yue, Soo Yeun Lee, Y Tom Tang, Mariah R Baughn, Vicki S Elliott, Brooke M Emerling, Ann He, Junming Yang, Shanya D Becha, Ian J Forsythe, Ann E Gorvad, Jayalaxmi Ramkumar, Brendan M Duggan, Joana X Li, Jennifer A Griffin, April JA Hafalia, Joseph P Marquis
  • Publication number: 20040253588
    Abstract: The invention provides human drug metabolizing enzymes (DME) and polynucleotides which identify and encode DME. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of DME.
    Type: Application
    Filed: August 28, 2003
    Publication date: December 16, 2004
    Inventors: Mariah R. Baughn, Christopher M. Bruns, Debopriya Das, Li Ding, Vicki S. Elliott, Ameena R. Gandhi, April J. A. Hafalia, Liam Kearney, Farrah A Khan, Preeti G. Lal, Ernestine A. Lee, Dyung Aina M. Lu, Yan Lu, Danniel B. Nguyen, Chandra S. Arvizu, Jayalaxmi Ramkumar, Huijun Z. Ring, Madhusudan M. Sanjanwala, Y.Tom Tang, Kavitha Tangavelu, Michael B. Thornton, Catherine M. Tribouley, Narinder K. Chawla, Yuming Xu, Junming Yang, Monique G. Yao, Henry Yue
  • Publication number: 20040254350
    Abstract: various embodiments of the invention provide human immune response associated proteins (TRAP) and polynucleotides which identify and encode IRAP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of IRAP.
    Type: Application
    Filed: March 19, 2004
    Publication date: December 16, 2004
    Inventors: Anne Ho, Mariah R Baughn, Shanya D Becha, Neil Burford, Vicki S Elliott, Brooke M Emerling, Ian J Forsythe, Ann E Gorvad, Jennifer A Griffin, April JA Hafalia, Cynthia D Honchell, John D Burrill, Julie J Blake, Preeti G Lal, Ernestine A Lee, Joseph P Marquis, Patricia M Lehr-Mason, Sally Lee, William W Sprague, Anita Swarnakar, Y Tom Tang, Bao Tran, Uyen K Tran, Umesh G Bhatia, Narinder K Chawla, Bridget A Warren, Wenjin Zheng, Yuming Xu, Henry Yue
  • Publication number: 20040253598
    Abstract: Various embodiments of the invention provide human vesicle-associated proteins (VAP) and polynucleotides which identify and encode VAP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of VAP.
    Type: Application
    Filed: March 31, 2004
    Publication date: December 16, 2004
    Inventors: Mariah R. Baughn, Ernestine A. Lee, Vicki S. Elliott, Brendan M. Duggan, Joana X. Li, Jennifer A. Griffin, April J.A. Hafalia, Angelo M. Delegeane, Soo Yeun Lee, Jayalaxmi Ramkumar, Amy E. Kable, Joseph P. Marquis, Rajagopal Gururajan, William W. (Webb) Sprague, Junming Yang, Kimberly J. Gietzen, Yeganeh Zebarjadian, Thomas W. Richardson, Alan A. Jackson, Xin Jiang, Shanya D. Becha
  • Publication number: 20040248249
    Abstract: Various embodiments of the invention provide human secreted proteins (SECP) and polynucleotides which identify and encode SECP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of SECP.
    Type: Application
    Filed: December 22, 2003
    Publication date: December 9, 2004
    Inventors: Uyen K Tran, Henry Yue, Bridget A Warren, Jennifer A Griffin, Thomas W Richardson, Ernestine A Lee, Mariah R Baughn, Neil Burford, Brendan M Duggan, Kavitha Thangavelu, Anita Swarnakar, Cynthia D Honchell, Roopa Reddy, Sally Lee, Kimberly J Gietzen, Y Tom Tang, Li Ding, Yalda Azimzai, Monique G Yao, Preeti G Lal, Brooke M Emerling, Yuming Xu, Ian J Forsythe, Vicki S Elliott, Shanya D Becha, Ameena R Gandhi, Patricia M Mason
  • Publication number: 20040248251
    Abstract: Various embodiments of the invention provide human receptors and membrane-associated proteins (REMAP) and polynucleotides which identify and encode REMAP. Embodiments of the invention also provide expression vectors, host cells, anti-bodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of REMAP.
    Type: Application
    Filed: July 7, 2004
    Publication date: December 9, 2004
    Inventors: Preeti G Lal, Cynthia D Honchell, Ian J Forsythe, Narinder K Chawla, Y Tom Tang, Mark L Borowsky, Ines Barroso, Henry Yue, Bridget A Warren, Kavitha Thangavelu, Kimberly J Gietzen, Yalda Azimzai, Ernestine A Lee, Mariah R Baughn, Ann E Gorvad, Brendan M Duggan, Bao Tran, Joana X Li, Thomas W Richardson, Vicki S Elliott, Yeganeh Zebarjadian, Uyen K Tran, Monique G Yao, David P Peterson, Wen Luo, Lehr-Mason Patricia
  • Publication number: 20040248243
    Abstract: The invention provides human lipid metabolism enzymes (LME) and polynucleotides which identify and encode LME. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with aberrant expression of LME.
    Type: Application
    Filed: July 11, 2002
    Publication date: December 9, 2004
    Inventors: Henry Yue, Jennifer L. Hillman, Mariah R. Baughn, Y. Tom Tang, Yalda Azimzai, Ameena R. Gandhi, Dyung Aina M. Lu, Danniel B. Nguyen, Narinder K. Walia
  • Publication number: 20040249127
    Abstract: Various embodiments of the invention provide human intracellular signaling molecules (INTSIG) and polynucleotides which identify and encode INTSIG. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of INTSIG.
    Type: Application
    Filed: January 12, 2004
    Publication date: December 9, 2004
    Inventors: Olga Bandman, Mariah R. Baughn, Shanya D. Becha, Anna M. Chinn, Benjamin G. Cocks, Li Ding, Ian J. Forsythe, Kimberly J. Gietzen, Jennifer A. Griffin, April J. A. Hafalia, Farrah A. Khan, Preeti G. Lal, Ernestine A. Lee, Joana X. Li, Dyung Aina M. Lu, Jayalaxmi Ramkumar, Thomas W. Richardson, Anita Swarnakar, Y Tom Tang, Narinder K. Chawla, Bridget A. Warren, Junming Yang, Monique G. Yao, Henry Yue, Yeganeh Zebarjadian
  • Publication number: 20040249128
    Abstract: Various embodiments of the invention provide human molecules for disease detection and treatment (MDDT) and polynucleotides which identify and encode MDDT. Embodiments of the invention also provide expression vectors, host cells, anti-bodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of MDDT.
    Type: Application
    Filed: July 19, 2004
    Publication date: December 9, 2004
    Inventors: Michael B Thornton, Janice K Au-Young, Yalda Azimzai, Olga Bandman, Ines Barroso, Mariah R Baughn, Shanya D Becha, Mark L Borowsky, Li Ding, Brendan M Duggan, Vicki S Elliott, Brooke M Emerling, Ian J Forsythe, Ameena R Gandhi, Kimberly J Gietzen, Ann E Gorvad, Jennifer A Griffin, Rajagopal Gururajan, April J A Hafalia, Huijun Z Ring, Craig H Ison, Karen Anne Jones, Preeti G Lal, Ernestine A Lee, Sally Lee, Joana X Li, Dyung Aina M Lu, Joseph P. Marquis, Patricia M. Lehr-Mason, Narinder K. Chawla, Chandra S. Arvizu, Bharati Sanjanwala, Thierry R. Sornasse, Anita Swarnakar, Y Tom Tang, Kavitha Thangavelu, Bao Tran, Uyen K. Tran, Bridget A. Warren, Yuming Xu, Monique G. Yao, Henry Yue, Huibin Yue, Yeganeh Zebarjadian, Hsin-Ru Chang
  • Publication number: 20040224911
    Abstract: The invention provides human transporters and ion channels (TRICH) and polynucleotides which identify and encode TRICH. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of TRICH.
    Type: Application
    Filed: February 3, 2003
    Publication date: November 11, 2004
    Inventors: Henry Yue, Michael B. Thornton, Jayalxmi Ramkumar, Y.Tom Tang, Yalda Azimzai, Mariah R. Baughn, Junming Yang, Monique G. Yao, Preeti G. Lal, Narinder K. Chawla, Ameena R. Gandhi, April J. A. Hafalia, Danniel B. Nguyen, Chandra S. Arvizu, Vicki S. Elliott, Catherine M. Tribouley, Dyung Aina M. Lu, Yuming Xu, Roopa M. Reddy, Roberto Hernandez, Mark L. Borowsky, Terence P. Lo, Yan Lu, Jennifer L. Policky, Barrie D. Greene, Madhusudan M. Sanjanwala, Brigitte E. Raumann, Neil Burford, Craig H. Ison, Ernestine A. Lee, Li Ding, Debopriya Das, Deborah A. Kallick, Farrah A. Khan, Jeffrey J. Seilhamer